TACK ROOM PRODUCTS, INC. – Trademark Portfolio
Entity Type: 03
TACK ROOM PRODUCTS, INC. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 4 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include GRADE I and MUSCLE MAX. The owner is based in ELMONT, NY.
253 HEMPSTEAD TURNPIKE
ELMONT, NY 11003
Showing of trademarks Trademarks
Trademark Classifications
TACK ROOM PRODUCTS, INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Leather and imitations of leather; animal skins, hides; trunks and travelling bags
Frequently Asked Questions
How many trademarks does TACK ROOM PRODUCTS, INC. have?
TACK ROOM PRODUCTS, INC. has 5 U.S. trademarks filed with the USPTO. Of these, 2 registered, 3 cancelled.
What trademark classes does TACK ROOM PRODUCTS, INC. file in?
TACK ROOM PRODUCTS, INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning), Class 18 (Leather Goods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are TACK ROOM PRODUCTS, INC.'s most well-known trademarks?
TACK ROOM PRODUCTS, INC.'s registered trademark portfolio includes well-known marks such as GRADE I and MUSCLE MAX. These are among 2 currently registered trademarks in the portfolio.
What is TACK ROOM PRODUCTS, INC.'s trademark registration success rate?
TACK ROOM PRODUCTS, INC. has a 40% trademark registration rate, with 2 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.